<!--#if expr="$title" --> <!--#echo var="title" --> <!--#else --> HIV Drug Resistance Database <!--#endif -->
Stanford University HIV Drug Resistance Database - A curated public database designed to represent, store, and analyze the divergent forms of data underlying HIV drug resistance.

Genbank References

BLAST search against GenBank file v. V 185.0 released on 2011-08-15
(search results include 129505 sequences from 1677 references)

This page contains a list of all GenBank entries on HIV-1 protease, RT and integrase grouped by reference. The reference may include a published paper or the title provided with the GenBank submission. The purpose of this page is to show which GenBank entries are in the HIV Drug Resistance Database and which aren't. The last column (Annotation) of the table shows whether or not there are plans to add the entry to the database. Each entry in the Annotation column is linked to a page explaining the annotation.

The entries were created by performing a BLAST search of the GenBank using the consensus B protease, RT and integrase amino acid sequence (give link to the sequences). The E-value column contains the lowest e-value (best match) for all the GenBank entries associated with a specific reference. The columns, # in GB, # in HIVDB, and % in HIVDB indicate the number of entries in GenBank associated with the reference, the number of these entries that are also in the HIV Drug Resistance Database, and the % of GenBank entries from a particular reference that are in the HIV Drug Resistance Database.

For a treatment summary for every isolate in our database and in the GenBank, click here. This file indicates whether or not the person from whom the sequenced virus was obtained had received one or more nucleoside RT inhibitor, nonnucleoside RT inhibitor, or protease inhibitor.


 

AuthorsTitleCitationE-value# in HIVDB# in Gb% in HIVDBAnnotation
Abecasis (2007) RECOMBINATION confounds the early evolutionary history of human immunodeficiency virus type 1: subtype g is a circulating recombinant form J. Virol. 81 (16), 8543-8551 (2007) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Abecasis (2011) Molecular epidemiological analysis of paired pol/env sequences from portuguese HIV-1 patients AIDS Res. Hum. Retroviruses (2011) In press 0  
154
18PR
154RT
0 Pending
Acharya (2009) Human immunodeficiency virus type 1 drug resistance mutations in patients from India Unpublished 1e-178  
1
1RT
0 Unpublished
Achkar (2004) INFECTION with group M non-B HIV-1 subtypes in individuals living in New York City Unpublished 1e-159  
34
34PR
3RT
0 ARV Rx and/or other data are N/A
Adachi (1986) PRODUCTION of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone J. Virol. 59 (2), 284-291 (1986) 1e-165 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Adojaan (2004) PREDOMINANCE of a Rare Type of HIV-1 in Estonia J. Acquir. Immune Defic. Syndr. 39 (5), 598-605 (2005) 0 4
4PR
4RT
4IN
143
142PR
4RT
4IN
2 Gene fragment(s)
Aghokeng (2007) FULL-LENGTH sequence analysis of SIVmus in wild populations of mustached monkeys (Cercopithecus cephus) from Cameroon provides evidence for two co-circulating SIVmus lineages Virology 360 (2), 407-418 (2007) 0 5
3PR
5RT
5IN
5
5RT
5IN
100 HIVDB
Aghokeng (2009) Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries Antivir. Ther. (Lond.) 14 (3), 401-411 (2009) 0 135
135PR
135RT
135
3PR
135RT
100 HIVDB
Aghokeng (2010) Extensive survey on the prevalence and genetic diversity of SIVs in primate bushmeat provides insights into risks for potential new cross-species transmissions Infect. Genet. Evol. (2009) In press 0  
20
2RT
20IN
0 Pending
Aghokeng (2010) Genetic diversity of simian lentivirus in wild De Brazza's monkeys (Cercopithecus neglectus) in Equatorial Africa J. Gen. Virol. 91 (PT 7), 1810-1816 (2010) 2e-70  
1
1IN
0 Pending
Aghokeng (2011) High Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity J. Clin. Microbiol. 49 (4), 1635-1641 (2011) 1e-176  
145
22PR
145RT
0 Pending
Agneskog (2008) CHANGES in mutation patterns of a mosaic genome HIV-1 strain after treatment with nucleoside analogs and the integrase inhibitor raltegravir Unpublished 1e-173  
4
2RT
2IN
0 Pending
Agwale (2003) GENOTYPIC and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive nigerian patients AIDS Res. Hum. Retroviruses 22 (1), 22-26 (2006) 5e-81 18
18PR
18RT
18
18PR
18RT
100 HIVDB
Agwu (2008) Analyses of HIV-1 Drug-Resistance Profiles Among Infected Adolescents Experiencing Delayed Antiretroviral Treatment Switch Following Initial Nonsuppressive Highly Active Antiretroviral Therapy Unpublished 1e-155  
155
146PR
31RT
0 Pending
Ahuka-Mundeke (2010) Full-length genome sequence a of Simian Immunodeficiency Viruses infecting a captive Agile Mangabey (Cercocebus agilis) is closely related to SIVrcm infecting red-capped mangabeys in Cameroon Unpublished 0 2
2PR
2RT
2IN
2
2RT
2IN
100 HIVDB
Ahumada-Ruiz (2009) Analysis of HIV-1 pol sequences from Panama: identification of phylogenetic clusters within subtype B and detection of antiretroviral drug resistance mutations Infect. Genet. Evol. 9 (5), 933-940 (2009) 0  
136
80PR
135RT
0 Pending
Ait-Khaled (2002) MUTATIONS in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy Antivir. Ther. (Lond.) 7 (1), 43-51 (2002) 1e-98 156
156RT
156
156RT
100 HIVDB
Albert (1992) PERSISTENCE of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera J. Virol. 66 (9), 5627-5630 (1992) 5e-55 20
20RT
20
20RT
100 HIVDB
Albert (1994) ANALYSIS of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes J. Virol. 68 (9), 5918-5924 (1994) 4e-77 23
23RT
26
26RT
88 HIVDB
Alcalde (2011) Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinants forms which is circulating in Sao Paulo city, Brazil Unpublished 1e-149  
14
12PR
8RT
0 Unpublished
Alexander (2002) INHIBITION of Human Immunodeficiency Virus Type 1 (HIV-1) Replication by a Two-Amino-Acid Insertion in HIV-1 Vif from a Nonprogressing Mother and Child J. Virol. 76 (20), 10533-10539 (2002) 0.027  
1
1IN
0 Gene fragment(s)
Ali (2010) Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones J. Med. Chem. 53 (21), 7699-7708 (2010) 1e-166  
6
3PR
4RT
0 Laboratory/experimental isolate
Alizon (1986) GENETIC variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients Cell 46 (1), 63-74 (1986) 1e-165 2
1PR
1RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Allan (1993) SPECIES-SPECIFIC diversity among simian immunodeficiency viruses from African green monkeys J. Virol. 65 (6), 2816-2828 (1991) 2e-33  
8
8IN
0 Laboratory/experimental isolate
Allen (2005) SELECTIVE Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution J. Virol. 79 (21), 13239-13249 (2005) 0  
14
14PR
14RT
14IN
0 Evolution/quasispecies study
Altfeld (2003) HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus Nature 420 (6914), 434-439 (2002) 0  
2
2PR
2RT
0 Case report(s) / study subset
Anderson (2000) TESTING the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E J. Virol. 74 (22), 10752-10765 (2000) 1e-164 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Anderson (1993) ANALYSIS of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques Virology 195 (2), 616-626 (1993) 5e-99  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Andersson (1999) MOLECULAR characterization of HIV-1 and HIV-2 in individuals from Guinea-Bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa Virology 261 (1999) In press 2e-66 7
7RT
7
7RT
100 HIVDB
Andreani (2008) CLINICAL evolution and antiretroviral resistance patterns in HIV-1 dual infected patients in Argentina Unpublished 1e-151  
71
62PR
40RT
0 Pending
Andresen (2007) CHARACTERIZATION of Near Full-Length Genomes of HIV Type 1 Strains in Denmark: Basis for a Universal Therapeutic Vaccine AIDS Res. Hum. Retroviruses 23 (11), 1442-1448 (2007) 0 17
17PR
17RT
17IN
17
13PR
17RT
17IN
100 HIVDB
Anta (2010) Identification of a new HIV-1 circulating recombinant form in Spain Unpublished 0  
4
4RT
0 Unpublished
Anton (2004) GENOTYPIC Resistance to Efavirenz/Protease Inhibitor Regimens Unpublished 0  
219
219PR
219RT
0 ARV Rx and/or other data are N/A
Apetrei (1998) HUMAN immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility J. Virol. 72 (5), 3534-3538 (1998) 1e-77 14
14RT
14
14RT
100 HIVDB
Apetrei (2003) HIV type 1 diversity in Northeastern Romania in 2000-2001 based on phylogenetic analysis of pol sequences from patients failing antiretroviral therapy AIDS Res. Hum. Retroviruses 19 (12), 1155-1161 (2003) 1e-117 163
77PR
86RT
163
77PR
86RT
100 HIVDB
Apetrei (2004) DIRECT Inoculation of Simian Immunodeficiency Virus from Sooty Mangabeys in Black Mangabeys (Lophocebus aterrimus): First Evidence of AIDS in a Heterologous African Species and Different Pathologic Outcomes of Experimental Infection J. Virol. 78 (21), 11506-11518 (2004) 4e-71  
18
18IN
0 Laboratory/experimental isolate
Apetrei (2005) MOLECULAR Epidemiology of Simian Immunodeficiency Virus SIVsm in U.S. Primate Centers Unravels the Origin of SIVmac and SIVstm J. Virol. 79 (14), 8991-9005 (2005) 4e-90 47
47IN
47
47IN
100 HIVDB
Apetrei (2006) POTENTIAL for HIV transmission through unsafe injections AIDS 20 (7), 1074-1076 (2006) 1e-148  
21
17PR
13RT
0 Pending
Apetrei (2007) SIVSMM Subtypes Induce Specific Immunologic and Virologic Changes in Naturally-Infected Sooty Mangabeys Unpublished 3e-70  
96
96IN
0 Pending
Arien (2005) REPLICATIVE fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time AIDS 19 (15), 1555-1564 (2005) 0 23
23PR
23RT
23
23RT
100 Case report(s) / study subset
Arnold (1995) AT least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England AIDS Res. Hum. Retroviruses 11 (3), 427-429 (1995) 1e-126  
4
4PR
0 Case report(s) / study subset
Arroyo (2004) HIV Type 1 Subtypes among Blood Donors in the Mbeya Region of Southwest Tanzania AIDS Res. Hum. Retroviruses 20 (8), 895-901 (2004) 0 20
20PR
20RT
20IN
20
20PR
20RT
20IN
100 HIVDB
Arroyo (2006) HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania AIDS 19 (14), 1517-1524 (2005) 0 14
14PR
14RT
14IN
14
8PR
14RT
14IN
100 HIVDB
Arruda (2009) Genetic diversity on the integrase region of the pol gene among HIV-1-infected patients naive for integrase inhibitors in Sao Paulo city, Brazil AIDS Res. Hum. Retroviruses 26, 1 (2010) 1e-168 76
76IN
76
76IN
100 HIVDB
Arruda (2010) Differences in frequencies of pi-resistance mutations from HIV-1 of different subtypes (B, C and F) in a cohort of patients failing arv therapy Unpublished 0  
869
245PR
787RT
0 Pending
Atkinson (2000) CORRELATION between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine J. Infect. Dis. 182 (2), 420-427 (2000) 1e-123 49
49PR
78
50PR
28RT
62 HIVDB
Aulicino (2004) CIRCULATION of novel HIV type 1 A, B/C, and F subtypes in Argentina AIDS Res. Hum. Retroviruses 21 (2), 158-164 (2005) 0 1
1PR
1RT
1IN
3
2PR
3RT
1IN
33 Case report(s) / study subset
Aulicino (2005) SEQUENCE Analysis of a South American HIV Type 1 BC Recombinant AIDS Res. Hum. Retroviruses 21 (10), 894-896 (2005) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Aulicino (2009) HIV-1 non-nucleoside resistance mutations K103N + L100I are strongly associated with nucleoside resistance mutation L74V in BF recombinants from Argentine children under treatment failure, and reduce susceptibility to Etravirine Antivir Ther. 2010;15(4):641-50 3e-52  
8
8PR
0 Pending
Auswinporn (2001) GENOTYPIC subtyping of the HIV-1 polymerase gene in 30 naave patients from Thailand Southeast Asian J. Trop. Med. Public Health 32 (2), 346-350 1e-121 6
6PR
6RT
27
27PR
27RT
22 HIVDB
Auwanit (2001) FULL-LENGTH sequences of two CRF01_ae (subtype e) HIV type 1 isolates from 1995 samples of patients with sexually transmitted diseases in Thailand AIDS Res. Hum. Retroviruses 17 (9), 867-871 (2001) 1e-165  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Auwanit (2009) Detection of drug resistance-associated and background mutations in human immunodeficiency virus type 1 CRF01_AE protease and reverse transcriptase derived from drug treatment-naive patients residing in central Thailand AIDS Res. Hum. Retroviruses 25 (6), 625-631 (2009) 1e-149 62
43PR
19RT
106
87PR
19RT
58 HIVDB
Avi (2009) Prevalence of Drug Resistance Mutations of Human Immunodeficiency Virus - 1 CRF06_cpx in Treatment-Naive Patients in Estonia in 2008 Unpublished 1e-144 55
55PR
55RT
55
55RT
100 HIVDB
Avi (2009) Polymorphisms of HIV-1 CRF06_cpx integrases in Estonia Unpublished 1e-164 112
112IN
114
114IN
98 HIVDB
AYEHUMIE (1991)   Unpublished (1991) 4e-41  
8
8PR
0 Gene fragment(s)
Ayouba (2009) Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Cote d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study AIDS Res. Hum. Retroviruses 25 (11), 1193-1196 (20 4e-51 105
105PR
105
105PR
100 HIVDB
Azevedo-Pereira (1998) COMPLETE nucleotide sequence of HIV-2ALI, a low infectious isolate with restricted tropism to primary CD4+ cells Unpublished 2e-97 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Babic (2005) PREVALENCE of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naive patients in Slovenia, 2000-2004 Virus Res. 118 (1-2), 156-163 (2006) 0 76
76PR
76RT
76
63PR
76RT
100 HIVDB
Babic (2005) MOLECULAR epidemiology of HIV-1 subtypes based on analysis of pol sequences in Slovenia, 1996-2005 J. Med. Virol. 78 (8), 997-1002 (2006) 0  
6
3PR
6RT
0 Case report(s) / study subset
Bacheler (2000) HUMAN immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy Antimicrob. Agents Chemother. 44 (9), 2475-2484 (2000) 1e-130 3669
3646PR
3662RT
3708
3708PR
3708RT
98 HIVDB
Bacheler (2001) GENOTYPIC correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy J. Virol. 75 (11), 4999-5008 (2001) 1e-126 87
84PR
87RT
87
84PR
87RT
100 HIVDB
Badreddine (2007) IDENTIFICATION and Characterization of HIV Type 1 Subtypes Present in the Kingdom of Saudi Arabia: High Level of Genetic Diversity Found AIDS Res. Hum. Retroviruses 23 (5), 667-674 (2007) 0 60
6PR
6RT
60IN
60
6RT
60IN
100 HIVDB
Baier (1990) COMPLETE nucleotide sequence of a simian immunodeficiency virus from African green monkeys: a novel type of intragroup divergence Virology 176 (1), 216-221 (1990) 1e-109 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Bailey (2007) EVOLUTION of HIV-1 in an HLA-B*57-Positive Patient during Virologic Escape J. Infect. Dis. 196 (1), 50-55 (2007) 0  
38
35RT
6IN
0 Evolution/quasispecies study
Bailey (2008) TRANSMISSION of Human Immunodeficiency Virus Type 1 from a Patient Who Developed AIDS to an Elite Suppressor J. Virol. 82 (15), 7395-7410 (2008) 0  
14
7PR
7RT
14IN
0 Case report(s) / study subset
Balakrishnan (2005) HIV Type 1 Genotypic Variation in an Antiretroviral Treatment-Naive Population in Southern India AIDS Res. Hum. Retroviruses 21 (4), 301-305 (2005) 1e-139 49
49PR
49RT
49
3PR
49RT
100 HIVDB
Baldanti (2010) Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimens J. Med. Virol. 82 (1), 116-122 (2010) 1e-156 11
11IN
11
11IN
100 HIVDB
Baldrich-Rubio (2001) A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa J. Gen. Virol. 82 (PT 5), 1095-1106 (2001) 1e-161 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Balode (2010) Direct Submission Submitted (26-JAN-2010) Department of Virology, Sw 7e-50  
1
1PR
0 Unpublished
Balode (2010) Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia J. Med. Virol. 82 (12), 2013-2018 (2010) 1e-148 107
107PR
107RT
107
79PR
67RT
100 HIVDB
Balode (2010) Direct Submission Submitted (26-JAN-2010) Department of Virology, Sw 1e-143  
6
5PR
4RT
0 Unpublished
Balode (2010) Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia J. Med. Virol. 82 (12), 2013-2018 (2010) 7e-49 2
2PR
2RT
2
2PR
100 HIVDB
Balode (2010) Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia J. Med. Virol. 82 (12), 2013-2018 (2010) 2e-48 3
3PR
3RT
3
3PR
100 HIVDB
Balotta (2000) PREVALENCE of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals Antivir. Ther. (Lond.) 5 (1), 7-14 (2000) 1e-128 71
33PR
38RT
71
33PR
38RT
100 HIVDB
Balotta (2000) PREVALENCE of multiple dideoxynucleoside analogue resistance (MddNR) in a multicentric cohort of HIV-1 Italian patients with virologic failure Unpublished 1e-133 149
132PR
149RT
157
137PR
157RT
94 HIVDB
Balotta (2001) INCREASING prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences J. Acquir. Immune Defic. Syndr. 27 (5), 499-505 (2001) 1e-100 19
19PR
19RT
19
19PR
19RT
100 HIVDB
Bang (2007) PREVALENCE of primary antiretroviral resistance: trends in Korea AIDS Res. Hum. Retroviruses 24 (1), 83-85 (2008) 0 81
81PR
81RT
81
77PR
81RT
100 HIVDB
Banke (2009) Positive selection pressure introduces secondary mutations at Gag cleavage sites in human immunodeficiency virus type 1 harboring major protease resistance mutations J. Virol. 83 (17), 8916-8924 (2009) 7e-52  
268
268PR
0 Pending
Bao (2008) MOLECULAR tracing of sexual HIV Type 1 transmission in the southwest border of China AIDS Res. Hum. Retroviruses 24 (5), 733-742 (2008) 0  
2
1PR
2RT
0 Case report(s) / study subset
Bar (2010) Wide variation in the multiplicity of HIV-1 infection among injection drug users J. Virol. 84 (12), 6241-6247 (2010) 3e-16  
390
390IN
0 Evolution/quasispecies study
Bar-Magen (2009) Comparative Biochemical Analysis of HIV-1 Subtype B and C Integrase Enzymes AIDS. 2010 Sep 10;24(14):2171-9. 1e-165  
2
2IN
0 Laboratory/experimental isolate
Barditch-Crovo (2001) PHASE i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults Antimicrob. Agents Chemother. 45 (10), 2733-2739 (2001) 4e-96 14
14RT
14
14RT
100 HIVDB
Barlow (2001) RECOMBINANT strains of HIV type 1 in the United Kingdom AIDS Res. Hum. Retroviruses 17 (5), 467-474 (2001) 1e-109  
12
12PR
9RT
0 ARV Rx and/or other data are N/A
Barlow (2003) CHARACTERIZATION of a novel simian immunodeficiency virus (SIVmonNG1) genome sequence from a mona monkey (Cercopithecus mona) J. Virol. 77 (12), 6879-6888 (2003) 3e-92 2
1PR
1RT
2IN
2
1RT
2IN
100 HIVDB
Barnett (1993) DISTINGUISHING features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain J. Virol. 67 (2), 1006-1014 (1993) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Barnett (1996) DIRECT Submission Submitted (11-OCT-1995) Barton Bryant, HIV Database, Los Ala 2e-98 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Barreto (2006) TRENDS in Antiretroviral Drug Resistance among HIV-1-Infected Blood Donors in Sao Paulo City, Brazil Unpublished 1e-142 6
6PR
6RT
6
4PR
3RT
100 HIVDB
Barrie (1996) NATURAL variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1 Virology 219 (2), 407-416 (1996) 1e-126  
37
37PR
0 Case report(s) / study subset
Bartolo (2007) ANALYSIS of HIV-1 protease and retrotranscriptase in drug-naive patients from Mozambique Unpublished 0 112
36PR
76RT
112
36PR
76RT
100 HIVDB
Bartolo (2007) MOLECULAR epidemiology of HIV-1 in Angola Unpublished 1e-170 140
19PR
121RT
140
19PR
121RT
100 HIVDB
Bartolo (2008) MOLECULAR epidemiology of HIV-1 infection in Maputo, Mozambique, and susceptibility to antiretroviral therapy Unpublished 1e-165 1
1PR
1RT
1
1RT
100 HIVDB
Bartolo (2009) Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic Infect. Genet. Evol. 9 (4), 672-682 (2009) 3e-49 9
9PR
9
9PR
100 HIVDB
Bartolo (2010) Origin and epidemiological history of CRF14_BG Unpublished 0 3
3PR
3RT
3IN
3
3RT
3IN
100 HIVDB
Baxter (2006) GENOTYPIC changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir J. Virol. 80 (21), 10794-10801 (2006) 0 1531
1531PR
1394RT
1534
394PR
1397RT
99 HIVDB
Beck (2007) OPTIMIZATION of the Oligonucleotide Ligation Assay (OLA), a Rapid and Inexpensive Test for Detection of HIV-1 Drug-Resistance Mutations, for Non-B Subtypes Unpublished 8e-53  
16
16PR
0 Case report(s) / study subset
Becker (1995) MOLECULAR and phylogenetic characterisation of a Guinea-Bissau-derived human immunodeficiency virus type 2 isolate Unpublished 1e-100 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Becker-Pergola (2000) ANALYSIS of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults AIDS Res. Hum. Retroviruses 16 (8), 807-813 (2000) 1e-115 54
27PR
27RT
54
27PR
27RT
100 HIVDB
Beer (1999) SIMIAN immunodeficiency virus (SIV) from sun-tailed monkeys (Cercopithecus solatus): evidence for host-dependent evolution of SIV within the C. lhoesti superspecies J. Virol. 73 (9), 7734-7744 (1999) 4e-97 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Beer (2000) PATTERNS of genomic sequence diversity among their simian immunodeficiency viruses suggest that L'Hoest monkeys (Cercopithecus lhoesti) are a natural lentivirus reservoir J. Virol. 74 (8), 3892-3898 (2000) 3e-99 3
3PR
3RT
3IN
3
2PR
3RT
3IN
100 HIVDB
Beer (2001) CHARACTERIZATION of novel simian immunodeficiency viruses from red-capped mangabeys from Nigeria (SIVrcmNG409 and -NG411) J. Virol. 75 (24), 12014-12027 (2001) 1e-133 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Beerenwinkel (2002) DIVERSITY and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype Proc. Natl. Acad. Sci. U.S.A. 99 (12), 8271-8276 (2002) 1e-126  
489
466PR
467RT
0 Sequence Quality
Bellocchi (2009) Subtype Analysis and Mutations to Antiviral Drugs in HIV-1-Infected Patients From Mozambique Before Initiation of Antiretroviral Therapy: Results From the DREAM Programme J Med Virol (2005) 1e-177 59
59PR
59RT
59
59RT
100 HIVDB
BENVENISTE (1988)   Unpublished (1990) 6e-99 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Bermudez-Aza (2011) Antiretroviral resistance in MSM in Brazil Unpublished 1e-153  
142
100PR
90RT
0 Unpublished
Bernardin (2003) PRIMARY Infection of a Male Plasma Donor with Divergent HIV Variants from the Same Source Followed by Rapid Fluctuations in Their Relative Frequency and Viral Recombination AIDS Res. Hum. Retroviruses 19 (11), 1009-1015 (2003) 0  
3
3PR
3RT
3IN
0 Case report(s) / study subset
Bernardin (2004) HUMAN immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes J. Virol. 79 (17), 11523-11528 (2005) 0 18
18PR
18RT
18IN
18
18PR
18RT
18IN
100 HIVDB
Bernardin (2006) DIRECT Submission Submitted (12-DEC-2005) Molecular Virology, Blood Systems Re 0 13
13PR
13RT
13IN
13
13PR
13RT
13IN
100 HIVDB
Bessong (2004) CHARACTERIZATION of Human Immunodeficiency Virus Type 1 from a Previously Unexplored Region of South Africa with a High HIV Prevalence AIDS Res. Hum. Retroviruses 21 (1), 103-109 (2005) 1e-168 26
13PR
13RT
26
13PR
13RT
100 HIVDB
Bessong (2005) RESISTANCE mutational analysis of HIV type 1 subtype C among rural South African drug-naive patients prior to large-scale availability of antiretrovirals AIDS Res. Hum. Retroviruses 22 (12), 1306-1312 (2006) 1e-177 70
35PR
35RT
70
35PR
35RT
100 HIVDB
Bessong (2010) Analysis of pol integrase gene sequences of HIV-1 infected treatment naive individuals in the Limpopo province of South Africa Unpublished 1e-164  
89
89IN
0 Pending
Bibollet-Ruche (1996) GENETIC diversity of simian immunodeficiency viruses from West African green monkeys: evidence of multiple genotypes within populations from the same geographical locale J. Virol. 71 (1), 307-313 (1997) 1e-30  
10
10IN
0 Gene fragment(s)
Bibollet-Ruche (2004) NEW simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade J. Virol. 78 (14), 7748-7762 (2004) 0 4
4PR
4RT
4IN
11
4PR
6RT
11IN
36 HIVDB
Bibollet-Ruche (2005) COMPLETE genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2) AIDS Res. Hum. Retroviruses 20 (12), 1377-1381 (2004) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Bibollet-Ruche (2005) GENETIC characterization of accessory genes from human immunodeficiency viruses type 1 group O Unpublished 3e-08  
14
14IN
0 Gene fragment(s)
Biesinger (2007) CHANGES in simian immunodeficiency virus reverse transcriptase alleles that appear during infection of macaques enhance infectivity and replication in CD4(+) T cells Virology 370 (1), 184-193 (2008) 0  
8
8RT
0 Case report(s) / study subset
Binverted question markelec (2000) HIGH levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure of protease inhibitor-containing antiretroviral combination therapy J. Infect. Dis. 181 (5), 1808-1812 (2000) 1e-128 100
100PR
100
100PR
100 HIVDB
Blankson (2007) ISOLATION and Characterization of Replication-Competent HIV-1 from a Subset of Elite Suppressors J. Virol. 81 (5), 2508-2518 (2007) 0  
6
4PR
6RT
6IN
0 Case report(s) / study subset
Blankson (2009) HIV-1 Evolution Following Transmission to an HLA-B*5801 Positive Subject J Infect Dis. 2009 Dec 15;200(12):1820-4. 0  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Bleiber (2001) INDIVIDUAL contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1 J. Virol. 75 (7), 3291-3300 (2001) 1e-112  
21
15PR
15RT
0 Case report(s) / study subset
Blick (2006) THE Probable Source of Both the Primary Multidrug-Resistant (MDR) HIV-1 Strain Found in a Patient with Rapid Progression to AIDS and a Second Recombinant MDR Strain Found in a Chronically HIV-1-Infected Patient J. Infect. Dis. 195 (9), 1250-1259 (2007) 1e-163  
13
1PR
13RT
0 Case report(s) / study subset
Bobkov (2004) DIVERSITY of HIV-1 Subtype A and CRF03_AB Protease in Eastern Europe: Selection of the V77I Variant Followed by Its Rapid Spread in IDU Populations Unpublished 5e-40 27
27PR
30
30PR
90 HIVDB
Bodelle (2004) IDENTIFICATION and Genomic Sequence of an HIV Type 1 Group N Isolate from Cameroon AIDS Res. Hum. Retroviruses 20 (8), 902-908 (2004) 0 1
1PR
1RT
1IN
1
1RT
1IN
100 HIVDB
Boeri (2003) EVOLUTIONARY characteristics of HIV-1 variants resistant to protease inhibitors in the absence of drug-selective pressure AIDS Res. Hum. Retroviruses (2003) In press 0  
18
18PR
18RT
0 Case report(s) / study subset
Bogh (2001) INVESTIGATING association between baseline HIV-1 genotypic resistance and virological response among protease in-hibitor-naive patients treated with HAART Unpublished 1e-133  
180
112PR
68RT
0 Unpublished
Bolivar (2009) The Challenge of HIV-1 Genetic Diversity: Discordant CD4+ T-Cell Count and Viral Load in an Untreated Patient Infected With a Subtype F Strain J. Acquir. Immune Defic. Syndr. 52 (5), 659-661 (2 1e-161  
1
1IN
0 Case report(s) / study subset
Bonhoeffer (2008) Evidence for positive epistasis in HIV-1 Science 306 (5701), 1547-1550 (2004) 1e-175 8676
8676PR
8676RT
8676
5624PR
7806RT
100 HIVDB
Bonhoeffer (2010) Evidence for positive epistasis in HIV-1 Science 306 (5701), 1547-1550 (2004) 9e-49 8
8PR
8RT
8
8PR
100 HIVDB
Bontell (2011) Transmitted drug resistance and phylogenetic analysis of HIV CRF01_AE in Northern Vietnam Infect. Genet. Evol. (2011) In press 2e-50 32
32PR
32RT
32
32PR
100 HIVDB
Bontell (2011) Transmitted drug resistance and phylogenetic analysis of HIV CRF01_AE in Northern Vietnam Infect. Genet. Evol. (2011) In press 2e-48 1
1PR
1RT
1
1PR
100 HIVDB
Bonura (2010) Transmission of drug-resistant HIV-1 strains in HAART-naive patients: a five-year retrospective study in Sicily, Italy Unpublished 0 109
109PR
109RT
109
41PR
109RT
100 HIVDB
Bouchard (2004) HIV Type 1 Drug Resistance among Naive Patients from Venezuela AIDS Res. Hum. Retroviruses 23 (3), 482-485 (2007) 1e-140 37
17PR
20RT
37
17PR
20RT
100 HIVDB
Bourara (2007) TARGET cell APOBEC3C can induce limited G-to-A mutation in HIV-1 PLoS Pathog. 3 (10), 1477-1485 (2007) 4e-52  
2
2PR
0 Case report(s) / study subset
Bouzeghoub (2005) HIGH Diversity of HIV Type 1 in Algeria AIDS Res. Hum. Retroviruses 22 (4), 367-372 (2006) 1e-149 248
133PR
116RT
248
132PR
116RT
100 HIVDB
Bouzeghoub (2008) FIRST Observation of HIV Type 1 Drug Resistance Mutations in Algeria AIDS Res. Hum. Retroviruses 24 (11), 1467-1473 (2008) 1e-148  
37
16PR
21RT
0 Pending
Brachtel (2002) DEMONSTRATION of de Novo HIV Type 1 Production by Detection of Multiply Spliced and Unspliced HIV Type 1 RNA in Paraffin-Embedded Tonsils AIDS Res. Hum. Retroviruses 18 (11), 785-790 (2002) 1e-62  
43
43PR
0 Evolution/quasispecies study
Bradshaw (2007) NOVEL Drug Resistance Pattern Associated with the Mutations K70G and M184V in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Antimicrob. Agents Chemother. 51 (12), 4489-4491 (2007) 0 9
4PR
9RT
9
9RT
100 HIVDB
Brandin (2003) POL Gene Sequence Variation in Swedish HIV-2 Patients Failing Antiretroviral Therapy AIDS Res. Hum. Retroviruses 19 (7), 543-550 (2003) 3e-97 30
30PR
30RT
30
30PR
30RT
100 HIVDB
Brann (2006) FUNCTIONAL Correlation between a Novel Amino Acid Insertion at Codon 19 in the Protease of Human Immunodeficiency Virus Type 1 and Polymorphism in the p1/p6 Gag Cleavage Site in Drug Resistance and Replication Fitness J. Virol. 80 (12), 6136-6145 (2006) 2e-49  
1
1PR
0 Case report(s) / study subset
Brehm (2011) Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase J. Acquir. Immune Defic. Syndr. 56 (4), 344-348 (2 0  
106
106RT
0 Pending
Brennan (1997) GENETIC variation in human immunodeficiency virus type 2: identification of a unique variant from human plasma AIDS Res. Hum. Retroviruses 13 (5), 401-404 (1997) 0.27 1
1PR
1RT
1IN
1
1RT
100 HIVDB
Brennan (2007) HIV-1 Strains Identified in Brazilian Blood Donors: Significant Prevalence of B/F1 Recombinants AIDS Res. Hum. Retroviruses 23 (11), 1434-1441 (2007) 1e-167 82
82IN
85
85IN
96 HIVDB
Brennan (2009) The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004 J. Acquir. Immune Defic. Syndr. 49 (4), 432-439 (2 1e-166 572
572IN
573
573IN
99 HIVDB
Brennan (2009) Identification of HIV-1 Non-B Subtypes and Antiretroviral Drug Resistant Strains in United States Blood Donors Unpublished 0 65
62PR
62RT
3IN
65
43PR
62RT
3IN
100 HIVDB
Brennan (2011) Expanded Evaluation of Blood Donors in the United States for HIV-1 Non-B Subtypes and Antiretroviral Drug Resistant Strains: 2005-2007 Unpublished 0  
25
8PR
25RT
0 Pending
Brenner (2006) HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture AIDS 20 (9), F9-F13 (2006) 0  
5
3PR
5RT
0 Pending
Brenner (2006) HIGH Rates of Forward Transmission Events after Acute/Early HIV-1 Infection J. Infect. Dis. 195 (7), 951-959 (2007) 0  
24
22PR
12RT
0 Case report(s) / study subset
Brenner (2010) HIV-1 Integrase Genotypic Analysis: Implications in the Study of HIV-1 Drug Resistance and Subtype Diversification Antimicrob. Agents Chemother. (2010) In press 0  
8
7RT
8IN
0 Unpublished
Brenner (2011) Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors J. Med. Virol. 83 (5), 751-759 (2011) 1e-167  
149
149IN
0 Pending
Brenner (2011) Spread of HIV-1 Drug-Resistant Sub-epidemics Unpublished 0  
1
1RT
0 Unpublished
Brigido (2005) SHORT Communication: Molecular Characteristics of HIV Type 1 Circulating in Sao Paulo, Brazil AIDS Res. Hum. Retroviruses 21 (7), 673-682 (2005) 0  
174
68PR
106RT
0 Pending
Brigido (2008) HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil AIDS Res. Hum. Retroviruses 23 (12), 1579-1586 (2007) 0 149
103PR
99RT
149
65PR
97RT
100 HIVDB
Brigido (2010) Southern Brazil HIV Type 1 C Expansion into the State of Sao Paulo, Brazil AIDS Res. Hum. Retroviruses 27 (3), 339-344 (2011) 0  
247
192PR
69RT
15IN
0 Pending
Brindeiro (1999) SEQUENCE diversity of the reverse transcriptase of human immunodeficiency virus type-1 from Brazilian untreated individuals Antimicrob. Agents Chemother. (1999) In press 2e-91 18
18RT
18
18RT
100 HIVDB
Brindeiro (2003) BRAZILIAN Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals AIDS 17 (7), 1063-1069 (2003) 1e-145 350
199PR
191RT
357
199PR
199RT
98 HIVDB
Briones (2000) DYNAMICS of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy Virus Res. 66 (1), 13-26 (2000) 1e-128  
186
180PR
186RT
0 Evolution/quasispecies study
Briones (2003) MEMORY in retroviral quasispecies: experimental evidence and theoretical model for human immunodeficiency virus J. Mol. Biol. 331 (1), 213-229 (2003) 1e-126  
15
15PR
15RT
0 Evolution/quasispecies study
Brown (2009) Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions J. Infect. Dis. 199 (3), 427-431 (2009) 1e-172  
160
133PR
77RT
0 Evolution/quasispecies study
Brown (1999) SEQUENCE clusters in human immunodeficiency virus type 1 reverse transcriptase are associated with subsequent virological response to antiretroviral therapy J. Infect. Dis. 180 (4), 1043-1049 (1999) 1e-130  
55
55PR
55RT
0 DNAChip
Brown (2005) BIOLOGIC and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines J. Virol. 79 (10), 6089-6101 (2005) 0 21
21PR
21RT
21IN
21
21PR
21RT
21IN
100 HIVDB
Brumme (2007) EVIDENCE of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1 PLoS Pathog. 3 (7), E94 (2007) 0 811
811PR
594RT
811
773PR
594RT
100 HIVDB
Brumme (2009) HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins PLoS ONE 4 (8), E6687 (2009) 0 1139
543PR
537RT
975IN
1285
415PR
691RT
1129IN
88 HIVDB
Bruselles (2009) Use of massive parallel pyrosequencing for near full-length characterization of a unique HIV BF recombinant associated with a fatal primary infection AIDS Res Hum Retroviruses. 2009 Sep;25(9):937-42. 0  
1
1PR
1RT
1IN
0 Pending
Buckton (2008) DEVELOPMENT and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance J. Antimicrob. Chemother. 62 (6), 1191-1198 (2008) 0  
17
17RT
0 Case report(s) / study subset
Bulgheroni (2001) UNUSUAL codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility J. Clin. Virol. 29 (1), 27-32 (2004) 4e-77  
3
3RT
0 Pending
Buonaguro (2006) SCREENING of HIV-1 isolates by reverse heteroduplex mobility assay and identification of non-B subtypes in Italy J. Acquir. Immune Defic. Syndr. 37 (2), 1295-1306 (2004) 0  
3
3RT
3IN
0 Case report(s) / study subset
Burda (2005) HIV-1 CRF09_cpx circulates in the North West Province of Cameroon where CRF02_AG infections predominate and recombinant strains are common AIDS Res. Hum. Retroviruses 20 (12), 1358-1363 (2004) 2e-50  
17
17PR
0 Sequence quality
Burda (2010) HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naive to HAART in Cameroon J. Med. Virol. 82 (2), 187-196 (2010) 1e-156 1
1RT
1
1RT
100 HIVDB
Burkala (2005) COMPARTMENTALIZATION of HIV-1 in the central nervous system: role of the choroid plexus AIDS 19 (7), 675-684 (2005) 1e-152  
140
123PR
140RT
0 Evolution/quasispecies study
Burns (2005) SEQUENCE variability of the integrase protein from a diverse collection of HIV type 1 isolates representing several subtypes AIDS Res. Hum. Retroviruses 18 (14), 1031-1041 (2002) 1e-159 21
21IN
21
21IN
100 HIVDB
Bussmann (2005) HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana Unpublished 0 71
71PR
71RT
71
64PR
71RT
100 HIVDB
Buzon (2011) Combined antiretroviral therapy and immune pressure lead to in vivo HIV-1 recombination with ancestral viral genomes J. Acquir. Immune Defic. Syndr. (2011) In press 4e-50  
8
8PR
0 Evolution/quasispecies study
Bychenko (2009) Isolation and characterization of new HIV-1 subtype A1 strain from Russia, envelope proteins variability analysis Unpublished 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Byrn (2006) HIV-1 in semen: an isolated virus reservoir Lancet 350 (9085), 1141 (1997) 4e-52  
35
35PR
0 Evolution/quasispecies study
Cabana (1999) EMERGENCE and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors J. Med. Virol. 59 (4), 480-490 (1999) 1e-125 92
54PR
38RT
92
54PR
38RT
100 HIVDB
Cabrera (2008) RALTEGRAVIR Susceptibility and Fitness Progression of HIV-1 Integrase in Patients on Long-Term Antiretroviral Therapy Unpublished 1e-167 135
135IN
135
135IN
100 HIVDB
Calazans (2003) LOW Accumulation of L90M in Protease from Subtype F HIV-1 with Resistance to Protease Inhibitors Is Caused by the L89M Polymorphism J. Infect. Dis. 191 (11), 1961-1970 (2005) 1e-126 51
51PR
51RT
52
52PR
51RT
98 HIVDB
Cali (2004) EVIDENCE for host-driven selection of the HIV type 1 vpr gene in vivo during HIV disease progression in a transfusion-acquired cohort AIDS Res. Hum. Retroviruses 21 (8), 728-733 (2005) 0  
15
15PR
15RT
15IN
0 Case report(s) / study subset
Calugi (2006) ENTIRE Genome of a Strain of Human Immunodeficiency Virus Type 1 with a Deletion of nef That Was Recovered 20 Years after Primary Infection: Large Pool of Proviruses with Deletions of env J. Virol. 80 (23), 11892-11896 (2006) 0  
1
1RT
1IN
0 Sequence quality
Calvez (2002) IMPACT of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial Antivir. Ther. (Lond.) 7 (3), 211-218 (2002) 2e-94  
26
26RT
0 ARV Rx and/or other data are N/A
Candotti (1999) AIDS in an HIV-seronegative Ghanaian woman with intersubtype A/G recombinant HIV-1 infection J. Med. Virol. 62 (1), 1-8 (2000) 1e-165  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Canducci (2008) DYNAMIC patterns of Human immunodeficiency virus type 1 (HIV-1) integrase gene evolution in patients failing Raltegravir based salvage therapies Unpublished 1e-154 37
37IN
37
37IN
100 HIVDB
Cao (2007) HIV subtype distribution in a cohort of HIV infected Ugandans: clinical implications Unpublished 0 46
45PR
46RT
46
26PR
46RT
100 HIVDB
Cardoso (2009) HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naive patients from Central West Brazil J. Clin. Virol. 46 (2), 134-139 (2009) 1e-145 76
76PR
76RT
76
76PR
8RT
100 HIVDB
Cardoso (2009) High level of multidrug resistance mutations in HIV type 1 pol gene and resistance-associated mutations to enfuvirtide (T-20) among antiretroviral-experienced patients from central Brazil AIDS Res. Hum. Retroviruses 25 (10), 943-950 (2009 1e-145 25
25PR
25RT
25
25PR
1RT
100 HIVDB
Cardoso (2010) HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil J. Med. Virol. 82 (3), 351-357 (2010) 1e-144  
62
62PR
4RT
0 Pending
Cardoso (2011) Molecular Characteristics of HIV Type 1 Infection Among Prisoners from Central Western Brazil AIDS Res. Hum. Retroviruses (2011) In press 2e-52  
18
18PR
0 Pending
Caride (2000) DRUG-RESISTANT reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART Virology 275 (1), 107-115 (2000) 5e-89  
14
14RT
0 ARV Rx and/or other data are N/A
Caride (2001) GENOTYPIC and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART Virus Genes 23 (2), 193-202 (2001) 1e-123 14
14PR
28
28PR
50 HIVDB
Carneiro-Proietti (1997) DIRECT Submission Submitted (14-NOV-1996) Lab. Virus, Dept. Microbiologia, Uni 1e-128  
1
1PR
0 Case report(s) / study subset
Caron (2008) HUMAN immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa AIDS Res. Hum. Retroviruses 24 (9), 1225-1228 (2008) 2e-50 4
4PR
4
4PR
100 HIVDB
Carr (1996) FULL-LENGTH sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand J. Virol. 70 (9), 5935-5943 (1996) 1e-165 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Carr (1998) FULL genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants Virology 247 (1), 22-31 (1998) 1e-164 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Carr (1999) CHARACTERIZATION of subtype A HIV-1 from Africa by full genome sequencing AIDS 13 (14), 1819-1826 (1999) 1e-166 7
7PR
7RT
7IN
7
7PR
7RT
7IN
100 HIVDB
Carr (1999) DIRECT Submission Submitted (07-JUL-1998) Molecular Epidemiology, Henry M. Jac 1e-164 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Carr (2001) THE AG Recombinant IbNG and Novel Strains of Group M HIV-1 are Common in Cameroon Virology (2001) In press 1e-166 7
7PR
7RT
7IN
7
7PR
7RT
7IN
100 HIVDB
Carr (2001) DIVERSE BF recombinants have spread widely since the introduction of HIV-1 into South America AIDS 15 (15), F41-F47 (2001) 1e-165 21
21PR
21RT
21IN
21
21PR
21RT
21IN
100 HIVDB
Carr (2004) OUTBREAK of a West African recombinant of HIV-1 in Tashkent, Uzbekistan J. Acquir. Immune Defic. Syndr. 39 (5), 570-575 (2005) 0 245
233PR
232RT
12IN
246
242PR
241RT
12IN
99 HIVDB
Carr (2005) HIV Subtype and Drug Resistance Patterns among Drug Naive Persons in Jos, Nigeria Unpublished 0 23
23PR
23RT
7IN
23
9PR
23RT
7IN
100 HIVDB
Carr (2006) FIRST report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina Unpublished 0 10
10PR
10RT
10IN
10
9PR
10RT
10IN
100 HIVDB
Carr (2006) HIGH Genetic Complexity of HIV-1 in low-prevalence, rural regions of Cameroon Unpublished 0 2
2PR
2RT
2IN
2
1PR
2RT
2IN
100 HIVDB
Carr (2008) HIV-1 in the Caribbean is Dominated by Subtype B PLoS One. 2009;4(3):e4814. Epub 2009 Mar 12. 1e-139  
62
59PR
27RT
0 Pending
Carr (2008) IDENTIFICATION of CRF17_BF in Four South American Countries Unpublished 0  
6
1PR
6RT
6IN
0 Pending
Carr (2008) HIV-1 Epidemic in the Caribbean is Dominated by Subtype B Unpublished 0  
15
10PR
15RT
15IN
0 Pending
Carr (2010) HIV-1 Recombinants with Multiple Parental Strains in Low-Prevalence, Remote Regions of Cameroon Retrovirology. 2010 Apr 28;7:39. 0 24
24PR
23RT
24IN
24
24RT
24IN
100 HIVDB
Carrera (2010) Identification of unusual and novel HIV type 1 spliced transcripts generated in vivo AIDS Res. Hum. Retroviruses 26 (7), 815-820 (2010) 0.002  
1
1IN
0 Gene fragment(s)
Carrion (2002) CIRCULATING Recombinant Form CRF02_AG in South America AIDS Res. Hum. Retroviruses 19 (4), 329-332 (2003) 1e-163 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Carrion (2004) DOCUMENTATION of subtype C HIV Type 1 strains in Argentina, Paraguay, and Uruguay AIDS Res. Hum. Retroviruses 20 (9), 1022-1025 (2004) 0 2
2PR
2RT
2IN
7
7PR
7RT
2IN
28 HIVDB
Carrion (2009) Molecular characterization of the human immunodeficiency virus type 1 among children in Lima, Peru AIDS Res. Hum. Retroviruses (2009) In press 1e-173  
2
2RT
0 Pending
Carvalho (2010) Primary Drug Resistance And HIV-1 Phylogenetic Diversity In North Brazil, Tocantins State Unpublished 1e-144 30
30PR
30RT
31
31PR
1RT
96 HIVDB
Carvalho (2010) Secondary Drug Resistance And HIV-1 Phylogenetic Diversity In North Brazil, Tocantins State Unpublished 4e-51  
5
5PR
0 Unpublished
Carvalho (2011)